Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype
Scott G Williams, Han Aw Yeang, Catherine Mitchell, Franco Caramia, David J Byrne, Stephen B Fox, Sue Haupt, Paul J Neeson, Ygal Haupt, View ORCID ProfileSimon P Keam
doi: https://doi.org/10.1101/2020.06.01.20115345
Scott G Williams
1Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
2Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
4Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Australia
Han Aw Yeang
3Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Australia
Catherine Mitchell
4Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Australia
Franco Caramia
2Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
David J Byrne
4Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Australia
Stephen B Fox
4Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Australia
Sue Haupt
2Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
5Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia
Paul J Neeson
3Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Australia
5Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia
Ygal Haupt
2Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
5Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia
7Department of Biochemistry and Molecular Biology, Monash University, Australia
Simon P Keam
2Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
3Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Australia
5Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia
Data Availability
Data are available upon reasonable request.
Posted June 02, 2020.
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype
Scott G Williams, Han Aw Yeang, Catherine Mitchell, Franco Caramia, David J Byrne, Stephen B Fox, Sue Haupt, Paul J Neeson, Ygal Haupt, Simon P Keam
medRxiv 2020.06.01.20115345; doi: https://doi.org/10.1101/2020.06.01.20115345
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype
Scott G Williams, Han Aw Yeang, Catherine Mitchell, Franco Caramia, David J Byrne, Stephen B Fox, Sue Haupt, Paul J Neeson, Ygal Haupt, Simon P Keam
medRxiv 2020.06.01.20115345; doi: https://doi.org/10.1101/2020.06.01.20115345
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (680)
- Anesthesia (182)
- Cardiovascular Medicine (2692)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12326)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4164)
- Geriatric Medicine (392)
- Health Economics (688)
- Health Informatics (2702)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3947)
- Nursing (214)
- Nutrition (587)
- Oncology (2076)
- Ophthalmology (596)
- Orthopedics (244)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1133)
- Primary Care Research (462)
- Public and Global Health (6590)
- Radiology and Imaging (1428)
- Respiratory Medicine (877)
- Rheumatology (415)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)